Discovered a new form of BCR signaling coordinated by multiprotein supercomplex formed by MYD88, TLR9, and BCR (My-T-BCR) in ibrutinib-responsive DLBCL. Here, TLR9 is linked to diffuse large B-cell lymphoma.